hepatic diseases, [6] and in the treatment of vitiligo, [7] Ruta montana L. contains various active principles able to inhibit the growth of mycobacteria, [8] The antioxidative effect of plant extracts is mainly due to phenolic components, such as flavonoids, [9] phenolic acids, and phenolic diterpenes. [10] In Algerian folk medicine, Ruta montana is used against child fevers and as an abortive drug. [11] This plant is abortive, it can produce gastro-enteritis, hypothermia and finally coma, [1, 11] the toxicity of this plant is due to the presence of methyluonylcetone, [12] and it is known that the presence of furocomarines can induce skin eruptions. [13] 
MATERIALS AND METHODS

Plant material
Ruta montana L. plant material was collected from Beni azize région, Wilaya of Sétif Northeast of Algeria during October, 2011, And identified by Professor Laouar Hocine, Department of Biology, Faculty of Natural and Life Sciences, University Ferhat Abbas, Sétif Algeria.
Animal material
Male and female Albino Wistar mice were used for acute toxicity and Albino Wistar rats for chronic toxicity. All experimental animals were obtained from Pasteur Institute (Algiers, Algeria). These animals were kept in the animal house of the faculty of Nature and Life Sciences, University of Sétif, at a temperature of 20°C and a photoperiod cycle of 12 hours light/dark. The animals were housed in plastic cages (5 rats or mice per cage) and had free access to standard commercial diet and tap water.
Preparation of plant extract
The areal parts were washed in running water, dried and powdered. The aqueous extract was prepared by adding 1l of distilled water (100°C) to 100 g of Ruta montana powder at room temperature during 72 h, the resulting decoction was filtered using wattman filter paper n°3 and then evaporated in rotary vacuum evaporator.
Acute toxicity study in mice
Albino Wistar mice of both sexes weighing between 18 and 22 g, were divided into seven groups, each containing 5 males and 5 females. The animals were fasted overnight (12 h ) with free access to water prior to administration of single doses (0, 2, 4, 6, 8, 10 and 12 g/kg b/w) of the extract dissolved in distilled water. Animals were gavaged by 1 ml/100 g b/w. The general behavior of the mice was continuously monitored after dosing, periodically during the first 24 h (with special attention given during the first 4 hours), and then daily thereafter, for a total of 14 days.
Chronic toxicity study in rats
Albino Wistar rats of both sexes weighing between 149 and 200 g were divided into four groups of 10 rats each (5 females and 5 males). The aqueous extract dissolved in distilled water, was administered daily by gavage for 90 days to groups I to IV (doses of 0, 100, 300 and 600 mg/kg, respectively). The animals were observed for signs of toxicity and mortality throughout the experimental period. At the end of the treatment, animals were fasted overnight, but allowed access to water and libitum. They were subsequently anesthetized with diethyl ether and blood samples were obtained by retro-orbital puncture [14] and collected in two tubes: tube 1 containing EDTA was processed immediately for hematological parameters analysis; tube 2 containing heparin was centrifuged at 4000 r/min at 4°C for 15 minutes to obtain serum (stored at −20°C until analysis). The organs (kidneys, liver, lungs, heart,) were weighed and fixed in 10% formalin for histopathological examination.
Urine samples
Urine (3-5 ml) was collected for urinalysis from rats which were kept 4 to 6 hr in metabolic cages.
Blood analysis
Hematological analysis was performed using an automatic hematological analyzer (Coulter STKS, Beckman). Parameters included: red blood cell (RBC) count, white blood cell (WBC) count, hemoglobin (Hb), hematocrit (Hct), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), mean corpuscular volume (VGM), platelets count and mean platelet volume (MPV). For biochemical analysis, the serum analysis for cholesterol (CHOL); glucose (GLU); creatinine (CREA); aspartate aminotransferase (AST); alanine aminotransferase (ALT); triglycerides (TG); uric acid (AU); alkaline phosphatase (ALP); creatine kinase (CK); albumin (ALB). Dosages were made using automatic analyzer (Beckman).
Organ weights
After the sacrifice of all animals, the kidneys, liver, heart, lungs, spleen, brain and stomach were carefully removed and weighed individually (absolute organ weight).
Liver and kidney tissues histopathological examination
After blood collection, rats were sacrificed, and their liver and kidneys were carefully dissected out, and rinsed in 0.9% NaCl, then fixed in the formol (10%), sectioned 5 µm thickness, and embedded in paraffin and stained with hematoxylin and eosin, [15] and examined with a light microscope (Carl Zeiss Jena, Germany).
Statistical analysis
The results are expressed as the mean value ± standard deviation. One-way analysis of variance followed by the Tukey test was performed to assess differences between groups. Differences were considered significant at p < 0.05. Statistical analyses were performed with the aid of the software GraphPad Prism 5 ® .
RESULTS
Acute toxicity
No death or toxicity signs such as diarrhea and vomiting were observed in the 14 day observation period after oral administration of single doses of the aqueous extract of Ruta montana L. Therefore, it could not be estimated an LD 50 could not be determined.
Chronic toxicity
No toxicity signs (diarrhea and vomiting) or death were recorded during the 90 consecutive days of treatment via oral route with Ruta Montana L. at doses of 0.1, 0.3 or 0.6 g/kg b/w.
Effect of Ruta montana L. aqueous extract on rats body weight
Changes in body weight of control and treated rats are presented in Figure 1 and Figure 2 . No significant difference in body weight changes was noted between the control and any of treated groups (1-4) at any time period.
Effect of Ruta montana L. aqueous extract on rats blood parameters
The hematological parameters of the treated and control groups are presented in Tables 1 and 2 . For female rats, no significant differences were recorded in any of the parameters examined at 30 and 90 days.
In the male groups, there was no significant differences observed in any of the parameters examined at 90 days, however, a significant decrease was noticed Values represent the mean ± S.D. (n = 10/group).
at 30 days (P < 0.05) in the red blood cells (RBC), Hematocrit (Hct), Hemoglobin (Hb), Platelets (PLT) in the dose 600 mg/kg and also a significant increases (P < 0.05) in the mean platelet volume (VPM) in the doses 300 or 600 mg/kg when compared to control group. The results indicated that all hematological parameters measured (white blood cell, red blood cell, hemoglobin, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, hematocrit, mean corpuscular volume, platelets and mean platelet volume) remained within physiological range throughout the treatment period (90 days).
The values for the biochemical parameters in treated and control rats are presented in Tables 3 and 4 . Oral administration of aqueous extract did not cause any significant differences in the biochemical parameters examined of the male and female rats.
Urinalysis
The urinalysis in the control and treated groups of both male and female rats were negative for glucose, bilirubin, ketones, blood, protein, nitrite and leukocytes.
Effect of Ruta montana L. aqueous extract on rats organs weight
Absolute and relative organ weights of 90 days treated rats are shown in Table 5 . There were no significant changes in the organs weight of the treated animals compared to the control groups.
Effect of Ruta montana L. aqueous extract on histomorphology of liver and kidneys in rats
Microscopic observations showed a normal liver histomorphology in control group ( Figure 3A) , However, the doses at 100, 300 and 600 mg/kg revealed a vascular congestion. The kidneys of control rats showed normal glomeruli and tubules (Figure 4 ), but the treated rats at the dose 100 mg/kg showed a vascular congestion. Chronic administration of Ruta montana L. extract at the other doses 300 and 600 mg/kg also showed a vascular congestion and lesions of interstitial nephrite.
DISCUSSION
This study tested the acute and chronic toxicity of the aqueous extract of Ruta montana L. this plant was orally
The results of the acute toxicity study indicated that Ruta montana L. extract via oral route with the doses from 2 to 12 g/kg body weight did not produce any sign of toxicity There was no significant difference or death in mice after 14 days of observation. According to the classification of Hodge and Sterner, [16] Chemical substances with a LD 50 between 5000 and 15000 mg/kg body weight determined after a single oral doses in rats is considered as practically non-toxic in humans. Therefore, the aqueous extract of Ruta montana L. could be considered practically non-toxic.
In the chronic toxicity study in rats receiving the Ruta montana L. extract orally at doses of 100, 300 or 600 mg/kg during 90 consecutive days, there was a slight change in the body weight, these changes were not significantly different in the treated groups compared to the control group. Since changes in body weight have been used as an indicator of adverse effects of drugs and chemicals, [17, 18] the present results suggest that at the chronic oral doses administered Ruta montana L. had no effect on the weight of rats. In addition, no significant changes were observed in the internal organ weight after the 90 days period. Generally, the reductions in internal organ weight are simple and sensitive indices of toxicity after exposure to toxic substances. [18, 19] The haematopoietic system is one of the most sensitive targets for toxic compounds, [20, 21] and an important index of physiological and pathological status in human and animals. [22] [23] [24] The changes in the hematological system have a higher predictive value for human toxicity when data are translated from animal studies. [25] [26] [27] In this study, the data of the hematological parameters showed no significant differences between the control and the treated groups, indicating that Ruta montana L. extract had no effects on the circulating blood cells nor on their production.
The transaminases (AST and ALT) are well-known enzymes used as good indicators of liver function [25] and as biomarkers predicting possible toxicity. [28] Generally, any damage to the parenchymal liver cells results in elevations of both transaminases in the blood. [23, 29] In addition, AST found in the serum is of both mitochondrial and cytoplasmic origin and any rise can be taken as a first sign of cell damage that leads to the outflow of the enzymes into the serum. [30] Therefore, no changes in ALT and AST activities suggest that the chronic administration of Ruta montana L. extract did not alter the hepatocytes function and metabolism. Equally, there was also no significant change in creatinine, between the treated groups and the control group. Indeed, creatinine is known as a good indicator of renal function and any rise in creatinine levels is only observed if there is marked damage to functional nephrons. [23] Thus, the results recorded in this study suggest that Ruta montana L. extract did not alter the renal function. The liver is the site of cholesterol disposal or degradation and its major site of synthesis. In the same perspective, the liver also controls glucose synthesis and generates free glucose from hepatic glycogen stores. As no significant changes were observed in glucose and cholesterol levels in this study, this suggests that Ruta montana L. had no effects on the lipid and carbohydrate metabolism of the rats. The other biochemical parameters such as ALB, Ck and TG showed no significant changes between treated groups and control group.
CONCLUSION
In conclusion, the present study indicated that the oral doses of Ruta montana L. consumed may be considered as relatively safe as they did not cause death or any signs of toxicity in both the acute and chronic toxicity studies in rodents.
